Point72 Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
29,000
+22,400
+339% +$7.99M 0.01% 1239
2025
Q4
$2.16M Buy
+6,600
New +$2.09M ﹤0.01% 2433
2019
Q2
Sell
-20,000
Closed -$3.8M 1316
2019
Q1
$3.8M Buy
+20,000
New +$3.82M 0.02% 605
2017
Q2
Sell
-298,500
Closed -$49M 818
2017
Q1
$49M Buy
+298,500
New +$49.6M 0.27% 94

Other funds holding AMGN

Point72 Asset Management's AMGN Position: Q4 2023 in Review

Point72 Asset Management sold out of Amgen (AMGN) in Q4 2023, closing a stake of 268,743 shares — an estimated $72.2M sold.

Point72 Asset Management first reported a position in AMGN in Q2 2014 and held it in 5 quarters. The position peaked at $72.2M in Q3 2023. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Point72 Asset Management reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 268,743 Amgen shares in Q4 2023, an estimated $72.2M.
  • Point72 Asset Management first reported a position in Amgen in Q2 2014 and held it in 5 quarters.
  • Point72 Asset Management's Amgen position peaked at $72.2M in Q3 2023.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.